1. Home
  2. BCHT vs LNSR Comparison

BCHT vs LNSR Comparison

Compare BCHT & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCHT

Birchtech Corp. Common Stock

N/A

Current Price

$1.40

Market Cap

55.2M

Sector

Industrials

ML Signal

N/A

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$5.28

Market Cap

63.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCHT
LNSR
Founded
N/A
2004
Country
United States
United States
Employees
20
N/A
Industry
Industrial Machinery/Components
Medical Electronics
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.2M
63.5M
IPO Year
2026
2005

Fundamental Metrics

Financial Performance
Metric
BCHT
LNSR
Price
$1.40
$5.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$10.00
AVG Volume (30 Days)
63.8K
31.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$58,435,000.00
Revenue This Year
$13.42
$10.06
Revenue Next Year
$61.22
$41.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.24
52 Week Low
$1.26
$4.95
52 Week High
$2.48
$13.20

Technical Indicators

Market Signals
Indicator
BCHT
LNSR
Relative Strength Index (RSI) 33.59 39.88
Support Level $1.26 $5.06
Resistance Level $1.58 $6.47
Average True Range (ATR) 0.13 0.18
MACD -0.02 -0.06
Stochastic Oscillator 9.44 34.74

Price Performance

Historical Comparison
BCHT
LNSR

About BCHT Birchtech Corp. Common Stock

Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: